Stevanato Group Reports Q3 Non-GAAP EPS of €0.16 and Revenue of €326.1M
Stevanato Group S.p.A. (STVN) has released its third-quarter financial results, reporting a Non-GAAP earnings per share (EPS) of €0.16 on revenue of €326.1 million. The report provides a snapshot of the company's current fiscal performance as it navigates shifting demand in the healthcare manufacturing sector. Looking ahead, the company has issued guidance projecting low single-digit growth for 2027. This cautious outlook is primarily attributed to an expected decline in syringe volumes related to GLP-1 medications from a specific customer, highlighting the impact of pharmaceutical market shifts on drug delivery component manufacturers.
Topics: earnings report EPS financial results revenue